Abstract
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to BrachytherapyReferences
- Contemporary management of borderline resectable pancreatic ductal adenocarcinoma.Ann Hepatobiliary Pancreat Surg. 2019; 23: 97https://doi.org/10.14701/AHBPS.2019.23.2.97
- Definition and management of borderline resectable pancreatic cancer.Surg Clin North Am. 2016; 96: 1337-1350https://doi.org/10.1016/J.SUC.2016.07.008
- Management of borderline resectable pancreatic cancer.Int J Radiat Oncol Biol Phys. 2018; 100: 1155-1174
- Contemporary management of localized resectable pancreatic cancer.Cancers (Basel). 2018; 10https://doi.org/10.3390/CANCERS10010024
- Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma.Arch Surg. 2012; 147: 753-760https://doi.org/10.1001/ARCHSURG.2012.1126
- Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.BMC Cancer. 2008; 8https://doi.org/10.1186/1471-2407-8-5
- Resection margins and R1 rates in pancreatic cancer—are we there yet?.Histopathology. 2008; 52: 787-796https://doi.org/10.1111/J.1365-2559.2007.02935.X
- Most pancreatic cancer resections are R1 resections.Ann Surg Oncol. 2008; 15: 1651-1660https://doi.org/10.1245/S10434-008-9839-8
- Impact of resection margin distance on survival of pancreatic cancer: a systematic review and meta-analysis.Cancer Res Treat. 2017; 49: 824-833https://doi.org/10.4143/CRT.2016.336
- Meta-analysis of radical resection rates and margin assessment in pancreatic cancer.Br J Surg. 2015; 102: 1459-1472https://doi.org/10.1002/BJS.9892
- Pancreatic adenocarcinoma, Version 2.2021.JNCCN J Natl Compr Cancer Netw. 2021; 19: 439-457https://doi.org/10.6004/JNCCN.2021.0017
Tuli R., Osipov A., Rutgers J.K., et al. Margin distance in resected pancreatic cancer independently predicts survival: implications for adjuvant radiation therapy using pelvic bone marrow hounsfield units to predict cytopenia during anal cancer chemoradiation E214. Int J Radiat Oncol Biol Phys. 2016;96(2S):E214. doi:10.1016/j.ijrobp.2016.06.1128
A directional 103Pd brachytherapy device: dosimetric characterization and practical aspects for clinical use | Elsevier Enhanced Reader. Available at: https://reader.elsevier.com/reader/sd/pii/S1538472116306110?token=5345C2587DCE7E874ECB7EA1EFEEABF8E6746A78C12D749E365E4FE84F8DFF68B2073CAFF19DE42A657C61EB638AFF53&originRegion=us-east-1&originCreation=20210823115422 Accessed August 23, 2021.
- Intraoperative implantation of a mesh of directional palladium sources (CivaSheet): dosimetry verification, clinical commissioning, dose specification, and preliminary experience.Brachytherapy. 2017; 16: 1257-1264https://doi.org/10.1016/J.BRACHY.2017.07.010
- First report on the feasibility of a permanently implantable uni-directional planar low dose rate brachytherapy sheet for patients with resectable or borderline resectable pancreatic cancer.Brachytherapy. 2021; 20: 207-217https://doi.org/10.1016/j.brachy.2020.08.010
Seneviratne D., McLaughlin C., Todor D., et al The CivaSheet: the new frontier of intraoperative radiation therapy or a pricier alternative to LDR brachytherapy? Adv Radiat Oncol. 2017;3(1):87–91. doi:10.1016/j.adro.2017.10.005
Article info
Publication history
Footnotes
Disclosures: The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article.
